Anthracycline cardiotoxicity in long-term survivors of childhood cancer: The light is not at the end of the tunnel.
Hudson
Melissa M
MM
Department of Oncology, Division of Cancer Survivorship, St. Jude Children's Research Hospital, the University of Tennessee, College of Medicine, Memphis, Tennessee 38105, USA. melissa.hudson@stjude.org
D000208:Acute Disease; D018943:Anthracyclines / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D064420:Drug-Related Side Effects and Adverse Reactions; D005500:Follow-Up Studies; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D006801:Humans; D007223:Infant; D007951:Leukemia, Myeloid / Q000175:diagnosis / Q000188:drug therapy*; D015999:Multivariate Analysis; D012307:Risk Factors; D017741:Survivors; D013995:Time; D016896:Treatment Outcome; D014463:Ultrasonography
D018943:Anthracyclines